Skip to Content

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.

Nadroparin Calcium

Scheme

Rec.INN

Therapeutic Categories

Anticoagulant agent

Heparin, low molecular weight - LMWH

Chemical Name

Calcium salt of a low molecular weight heparin fraction.

Foreign Names

  • Nadroparinum calcicum (Latin)
  • Nadroparin calcium (German)
  • Nadroparine calcique (French)
  • Nadroparina calcica (Spanish)

Generic Names

  • Nadroparin Calcium (OS: BAN)
  • Nadroparine calcique (OS: DCF)
  • CY 216 (IS: Sanofi)
  • Heparin, niedermolekular 4-5 calcium (IS)
  • Nadroparin Calcium (PH: BP 2010, Ph. Eur. 6)
  • Nadroparin-Calcium (PH: Ph. Eur. 6)
  • Nadroparine calcique (PH: Ph. Eur. 6)
  • Nadroparinum calcicum (PH: Ph. Eur. 6)

Brand Names

  • Fraxiforte
    GlaxoSmithKline, Switzerland
  • Fraxiparin
    GlaxoSmithKline, Austria; GlaxoSmithKline, Costa Rica; GlaxoSmithKline, Germany; GlaxoSmithKline, Dominican Republic; GlaxoSmithKline, Georgia; GlaxoSmithKline, Guatemala; GlaxoSmithKline, Honduras; GlaxoSmithKline, Israel; GlaxoSmithKline, Nicaragua; GlaxoSmithKline, Panama; GlaxoSmithKline, El Salvador
  • Fraxiparina
    Glaxo SmithKline, Spain; GlaxoSmithKline, Italy; GlaxoSmithKline, Portugal
  • Fraxiparine
    Glaxo Wellcome, Bulgaria; GlaxoSmithKline, Argentina; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bulgaria; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Chile; GlaxoSmithKline, China; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Ecuador; GlaxoSmithKline, Estonia; GlaxoSmithKline, France; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Indonesia; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Latvia; GlaxoSmithKline, Mexico; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Oman; GlaxoSmithKline, Peru; GlaxoSmithKline, Philippines; GlaxoSmithKline, Poland; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovenia; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Thailand; GlaxoSmithKline, Tunisia; GlaxoSmithKline, Turkey; GlaxoSmithKline, Venezuela; GlaxoSmithKline, South Africa; Sanofi-Aventis, Colombia; Sanofi-Aventis, Dominican Republic; Sanofi-Aventis, Taiwan
  • Fraxodi
    Euro, Netherlands; GlaxoSmithKline, Belgium; GlaxoSmithKline, Germany; GlaxoSmithKline, France; GlaxoSmithKline, Hungary; GlaxoSmithKline, Italy; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Oman; GlaxoSmithKline, Poland; GlaxoSmithKline, Portugal; GlaxoSmithKline, Tunisia; GlaxoSmithKline, Turkey; Medcor, Netherlands
  • Seledie
    Glaxo Allen, Italy
  • Seleparina
    Italfarmaco, Italy

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.



Hide